Company

Gilead Sciences Inc

NASDAQ:GILD

Gilead Sciences Inc is a biopharmaceutical company. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. Gilead Sciences Inc offers products in HIV, Onocolgy, Liver Disease, Vekulaery and Other.

86 stories · page 5 of 5

Media

U.S. Risers/Fallers: McDonald’s, Valeant, Synergetics, Intel, Gilead, H&R Block, Navistar, Ambarella, Guidewire Software

By Proactive 02/09/2015

Media

U.S. Risers/Fallers: McDonald’s, Intel, Gilead, H&R Block, Navistar, Ambarella, Guidewire Software

By Proactive 02/09/2015

Media

Wednesday’s most followed in U.S. including Twitter, Citrix Systems, Garmin, Akamai Technologies, Gilead Sciences, GlaxoSmithKline, Altria, Anthem, Hilton, Hess

By Proactive 29/07/2015

Media

Wall Street to open higher before Fed release; Citrix jumps, Twitter tumbles

U.S. stock index futures rose today on hopes that Beijing could stem the rout in its markets and ahead of a statement from the U.S. Federal Reserve that could give clues regarding the timing of a rate hike. S&P 500 futures rose 0.2 perc

By Proactive 29/07/2015

Medical technology & services

Gilead rises on higher than expected revenues and earning in second quarter

By Proactive 29/07/2015

Pharma & Biotech

AstraZeneca "to miss out on US drug deal" - sources

Receptos is said to have rebuffed $200 per share bid approach from AstraZeneca

By Proactive 09/06/2015